{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:42:52Z","timestamp":1792719772726,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":4252,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s13311-011-0087-4","type":"journal-article","created":{"date-parts":[[2011,11,28]],"date-time":"2011-11-28T13:41:53Z","timestamp":1322487713000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Novel Treatment Targets for Cerebral Edema"],"prefix":"10.1016","volume":"9","author":[{"given":"Brian P.","family":"Walcott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher T.","family":"Kahle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Marc","family":"Simard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-011-0087-4_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJM200101253440404","article-title":"Risk factors for cerebral edema in children with diabetic ketoacidosis. The Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics","volume":"344","author":"Glaser","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0087-4_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0030-1261886","article-title":"Disruption of endothelial tight junctions in a patient with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS)","volume":"41","author":"Matsuzaki","year":"2010","journal-title":"Neuropediatrics"},{"key":"10.1007\/s13311-011-0087-4_bib3","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jocn.2011.01.014","article-title":"Cerebral edema and a transtentorial brain herniation syndrome associated with pandemic swine influenza A (H1N1) virus infection","volume":"18","author":"Kahle","year":"2011","journal-title":"J Clin Neurosci"},{"key":"10.1007\/s13311-011-0087-4_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/nrclinonc.2009.14","article-title":"VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer","volume":"6","author":"Gerstner","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1007\/s13311-011-0087-4_bib5","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000113736","article-title":"Predictors of life-threatening brain edema in middle cerebral artery infarction","volume":"25","author":"Hofmeijer","year":"2008","journal-title":"Cerebrovasc Dis"},{"key":"10.1007\/s13311-011-0087-4_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1474-4422(09)70047-X","article-title":"Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial","volume":"8","author":"Hofmeijer","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11940-010-0110-9","article-title":"Managing malignant cerebral infarction","volume":"13","author":"Simard","year":"2011","journal-title":"Curr Treat Options Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib8","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1212\/01.wnl.0000305961.68029.54","article-title":"Diffusion tensor imaging of acute mild traumatic brain injury in adolescents","volume":"70","author":"Wilde","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0087-4_bib9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/WCO.0b013e328337f451","article-title":"Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments","volume":"23","author":"Donkin","year":"2010","journal-title":"Curr Opin Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib10","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S1474-4422(07)70055-8","article-title":"Brain oedema in focal ischaemia: molecular pathophysiology and theoretical implications","volume":"6","author":"Simard","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.neuroscience.2004.06.046","article-title":"Edema and brain trauma","volume":"129","author":"Unterberg","year":"2004","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-011-0087-4_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.ph.58.030196.003155","article-title":"Pathophysiology of the aquaporin water channels","volume":"58","author":"King","year":"1996","journal-title":"Annu Rev Physiol"},{"key":"10.1007\/s13311-011-0087-4_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/72256","article-title":"Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke","volume":"6","author":"Manley","year":"2000","journal-title":"Nat. Med"},{"key":"10.1007\/s13311-011-0087-4_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00004647-200204000-00001","article-title":"Aquaporins in brain: distribution, physiology, and pathophysiology","volume":"22","author":"Badaut","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-011-0087-4_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nrn1252","article-title":"The molecular basis of water transport in the brain","volume":"4","author":"Amiry-Moghaddam","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1007\/s13311-011-0087-4_bib16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/jnr.20819","article-title":"Time course of aquaporin expression after transient focal cerebral ischemia in mice","volume":"83","author":"Ribeiro","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-011-0087-4_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0306-4522(03)00425-1","article-title":"Activation of voltage-sensitive sodium channels during oxygen deprivation leads to apoptotic neuronal death","volume":"126","author":"Banasiak","year":"2004","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-011-0087-4_bib18","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1523\/JNEUROSCI.23-12-05061.2003","article-title":"Na-K-Cl Cotransporter Contributes to Glutamate-Mediated Excitotoxicity","volume":"23","author":"Beck","year":"2003","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-011-0087-4_bib19","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0028-3908(00)00027-7","article-title":"Inhibition of different pathways influencing Na + homeostasis protects organotypic hippocampal slice cultures from hypoxic\/hypoglycemic injury","volume":"39","author":"Breder","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-011-0087-4_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archneur.1996.00550040037012","article-title":"\"Malignant\" middle cerebral artery territory infarction: clinical course and prognostic signs","volume":"53","author":"Hacke","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3171\/jns.2004.100.3.0376","article-title":"Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial","volume":"100","author":"Cruz","year":"2004","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-011-0087-4_bib22","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1097\/00005373-199806000-00003","article-title":"Neurogenic hypotension in patients with severe head injuries","volume":"44","author":"Chesnut","year":"1998","journal-title":"J Trauma"},{"key":"10.1007\/s13311-011-0087-4_bib23","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3171\/jns.1992.77.4.0584","article-title":"Aggravation of vasogenic cerebral edema by multiple-dose mannitol","volume":"77","author":"Kaufmann","year":"1992","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-011-0087-4_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1227\/01.NEU.0000175726.08903.0A","article-title":"Effects of 23.4% sodium chloride solution in reducing intracranial pressure in patients with traumatic brain injury: a preliminary study","volume":"57","author":"Ware","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-011-0087-4_bib25","first-page":"277","article-title":"The use of 23.4% hypertonic saline for the management of elevated intracranial pressure in patients with severe traumatic brain injury: a pilot study","volume":"67","author":"Kerwin","year":"2009","journal-title":"J Trauma"},{"key":"10.1007\/s13311-011-0087-4_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1152\/ajplegacy.1919.48.4.531","article-title":"Experimental alteration of brain bulk","volume":"48","author":"Weed","year":"1919","journal-title":"Am J Physiol -- Legacy Content"},{"key":"10.1007\/s13311-011-0087-4_bib27","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1097\/00003246-200009000-00032","article-title":"Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension","volume":"28","author":"Qureshi","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-011-0087-4_bib28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1212\/01.wnl.0000304042.05557.60","article-title":"Reversal of transtentorial herniation with hypertonic saline","volume":"70","author":"Koenig","year":"2008","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0087-4_bib29","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1097\/CCM.0b013e3181847853","article-title":"The perivascular pool of aquaporin-4 mediates the effect of osmotherapy in postischemic cerebral edema","volume":"36","author":"Zeynalov","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-011-0087-4_bib30","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/SHK.0b013e3181e68649","article-title":"Impact of hypertonic saline on the release of selected cytokines after stimulation with LPS or peptidoglycan in ex vivo whole blood from healthy humans","volume":"34","author":"Gundersen","year":"2010","journal-title":"Shock"},{"key":"10.1007\/s13311-011-0087-4_bib31","doi-asserted-by":"crossref","first-page":"R1224","DOI":"10.1152\/ajpregu.2001.281.4.R1224","article-title":"Cardiovascular changes induced by central hypertonic saline are accompanied by glutamate release in awake rats","volume":"281","author":"Jin","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1007\/s13311-011-0087-4_bib32","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1152\/japplphysiol.01560.2005","article-title":"Possible new mechanism underlying hypertonic saline therapy for cerebral edema","volume":"100","author":"Chodobski","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1007\/s13311-011-0087-4_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00008506-200201000-00005","article-title":"Treatment of transtentorial herniation unresponsive to hyperventilation using hypertonic saline in dogs: effect on cerebral blood flow and metabolism","volume":"14","author":"Qureshi","year":"2002","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1007\/s13311-011-0087-4_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00003246-200202000-00028","article-title":"Regional intraparenchymal pressure differences in experimental intracerebral hemorrhage: effect of hypertonic saline","volume":"30","author":"Qureshi","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-011-0087-4_bib35","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/01.CCM.0000295306.52783.1E","article-title":"Effect of hypertonic saline concentration on cerebral and visceral organ water in an uninjured rodent model","volume":"36","author":"Toung","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-011-0087-4_bib36","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00006123-199905000-00064","article-title":"Treatment of elevated intracranial pressure in experimental intracerebral hemorrhage: comparison between mannitol and hypertonic saline","volume":"44","author":"Qureshi","year":"1999","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-011-0087-4_bib37","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00003246-199806000-00038","article-title":"Treatment of refractory intracranial hypertension with 23.4% saline","volume":"26","author":"Suarez","year":"1998","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-011-0087-4_bib38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1227\/01.NEU.0000359533.16214.04","article-title":"Hypertonic saline and its effect on intracranial pressure, cerebral perfusion pressure, and brain tissue oxygen","volume":"65","author":"Rockswold","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-011-0087-4_bib39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.STR.21.6.874","article-title":"Treatment of right hemispheric cerebral infarction by hemicraniectomy","volume":"21","author":"Delashaw","year":"1990","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0087-4_bib40","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/01.STR.29.9.1888","article-title":"Early hemicraniectomy in patients with complete middle cerebral artery infarction","volume":"29","author":"Schwab","year":"1998","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0087-4_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0090-3019(94)90210-0","article-title":"Bilateral decompressive craniectomy for worsening coma in acute subarachnoid hemorrhage. Observations in support of the procedure","volume":"41","author":"Fisher","year":"1994","journal-title":"Surg Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib42","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/00006123-199706000-00010","article-title":"One-year outcome after decompressive surgery for massive nondominant hemispheric infarction","volume":"40","author":"Carter","year":"1997","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-011-0087-4_bib43","first-page":"270","article-title":"Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction","volume":"75","author":"Uhl","year":"2004","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1007\/s13311-011-0087-4_bib44","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/STROKEAHA.107.485649","article-title":"Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial","volume":"38","author":"J\u00fcttler","year":"2007","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0087-4_bib45","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1161\/STROKEAHA.107.485235","article-title":"Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial)","volume":"38","author":"Vahedi","year":"2007","journal-title":"Stroke"},{"issue":"suppl 1","key":"10.1007\/s13311-011-0087-4_bib46","first-page":"A426","article-title":"Hemicraniectomy and durotomy upon deterioration from infarction related swelling trial (HeADDFIRST): first public presentation of the primary study findings","volume":"60","author":"Frank","year":"2003","journal-title":"Neurology"},{"key":"10.1007\/s13311-011-0087-4_bib47","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3171\/JNS\/2008\/109\/8\/0287","article-title":"Aggravation of infarct formation by brain swelling in a large territorial stroke: a target for neuroprotection?","volume":"109","author":"Walberer","year":"2008","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-011-0087-4_bib48","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJMoa1102077","article-title":"Decompressive craniectomy in diffuse traumatic brain injury","volume":"364","author":"Cooper","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1007\/s13311-011-0087-4_bib49","first-page":"129","article-title":"Barbiturates as protective agents in brain ischemia and as free radical scavengers in vitro","volume":"492","author":"Smith","year":"1980","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1007\/s13311-011-0087-4_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000064","article-title":"Corticosteroids for acute ischaemic stroke","volume":"2","author":"Qizilbash","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1007\/s13311-011-0087-4_bib51","first-page":"133","article-title":"Brain edema: a classification based on blood\u2013brain barrier integrity","volume":"1","author":"Betz","year":"1989","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"10.1007\/s13311-011-0087-4_bib52","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1161\/01.STR.18.4.751","article-title":"Regional brain sodium, potassium, and water changes in the rat middle cerebral artery occlusion model of ischemia","volume":"18","author":"Young","year":"1987","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0087-4_bib53","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/ncpneuro0883","article-title":"Roles of the cation-chloride cotransporters in neurological disease","volume":"4","author":"Kahle","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/00004647-200106000-00009","article-title":"Na + \u2212K + \u2212Cl- cotransporter in rat focal cerebral ischemia","volume":"21","author":"Yan","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-011-0087-4_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0006-8993(02)03832-5","article-title":"Inhibition of Na(+)-K(+)-Cl(\u2212) cotransporter during focal cerebral ischemia decreases edema and neuronal damage","volume":"961","author":"Yan","year":"2003","journal-title":"Brain Res"},{"key":"10.1007\/s13311-011-0087-4_bib56","doi-asserted-by":"crossref","first-page":"C1147","DOI":"10.1152\/ajpcell.00538.2001","article-title":"Astrocytes from Na + \u2212K + \u2212Cl \u2212 cotransporter-null mice exhibit absence of swelling and decrease in EAA release","volume":"282","author":"Su","year":"2002","journal-title":"American J Physiol Cell Physiol"},{"key":"10.1007\/s13311-011-0087-4_bib57","doi-asserted-by":"crossref","first-page":"C1136","DOI":"10.1152\/ajpcell.00478.2001","article-title":"Contribution of Na + \u2212K + \u2212Cl \u2212 cotransporter to high-[K+]o- induced swelling and EAA release in astrocytes","volume":"282","author":"Su","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1007\/s13311-011-0087-4_bib58","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1179\/016164105X25243","article-title":"The role of Na-K-Cl co-transporter in cerebral ischemia","volume":"27","author":"Chen","year":"2005","journal-title":"Neurol Res"},{"key":"10.1007\/s13311-011-0087-4_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1535-7511.2006.00119.x","article-title":"Wrong-way chloride transport: is it a treatable cause of some intractable seizures?","volume":"6","author":"Staley","year":"2006","journal-title":"Epilepsy Curr"},{"issue":"9","key":"10.1007\/s13311-011-0087-4_bib60","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1111\/j.1528-1167.2011.03203.x","article-title":"Diuretics and epilepsy: will the past and present meet?","volume":"52","author":"Maa","year":"2011","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-011-0087-4_bib61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/CCM.0B013E31816590C4","article-title":"NKCC1-mediated traumatic brain injury-induced brain edema and neuron death via Raf\/MEK\/MAPK cascade","volume":"36","author":"Lu","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-011-0087-4_bib62","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1179\/016164107X204738","article-title":"Bumetanide administration attenuated traumatic brain injury through IL-1 overexpression","volume":"29","author":"Lu","year":"2007","journal-title":"Neurol Res"},{"key":"10.1007\/s13311-011-0087-4_bib63","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ejphar.2006.07.048","article-title":"Inhibition of the Na + \u2212K + \u22122Cl- cotransporter in choroid plexus attenuates traumatic brain injury-induced brain edema and neuronal damage","volume":"548","author":"Lu","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-011-0087-4_bib64","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.jcbfm.9600006","article-title":"Na(+)-dependent chloride transporter (NKCC1)-null mice exhibit less gray and white matter damage after focal cerebral ischemia","volume":"25","author":"Chen","year":"2005","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1007\/s13311-011-0087-4_bib65","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm1390","article-title":"Newly expressed SUR1-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke","volume":"12","author":"Simard","year":"2006","journal-title":"Nat Med"},{"key":"10.1007\/s13311-011-0087-4_bib66","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3171\/2009.11.JNS081052","article-title":"Molecular mechanisms of microvascular failure in central nervous system injury \u2014 synergistic roles of NKCC1 and SUR1\/TRPM4","volume":"113","author":"Simard","year":"2010","journal-title":"J Neurosurg"},{"key":"10.1007\/s13311-011-0087-4_bib67","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1111\/j.1528-1167.2011.03111.x","article-title":"Anomalous levels of Cl- transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex","volume":"52","author":"Conti","year":"2011","journal-title":"Epilepsia"},{"key":"10.1007\/s13311-011-0087-4_bib68","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1158\/0008-5472.CAN-09-4666","article-title":"Inhibition of the sodium-potassium-chloride cotransporter isoform-1 reduces glioma invasion","volume":"70","author":"Haas","year":"2010","journal-title":"Cancer Res"},{"key":"10.1007\/s13311-011-0087-4_bib69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.physiol.61.1.337","article-title":"ATP-sensitive potassium channels: a model of heteromultimeric potassium channel\/receptor assemblies","volume":"61","author":"Seino","year":"1999","journal-title":"Annu Rev Physiol"},{"key":"10.1007\/s13311-011-0087-4_bib70","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1152\/japplphysiol.00763.2005","article-title":"Plasma arginine-vasopressin following experimental stroke: effect of osmotherapy","volume":"100","author":"Chang","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1007\/s13311-011-0087-4_bib71","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1523\/JNEUROSCI.21-17-06512.2001","article-title":"Cell swelling and a nonselective cation channel regulated by internal Ca2+ and ATP in native reactive astrocytes from adult rat brain","volume":"21","author":"Chen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-011-0087-4_bib72","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.1523\/JNEUROSCI.23-24-08568.2003","article-title":"Functional coupling between sulfonylurea receptor type 1 and a nonselective cation channel in reactive astrocytes from adult rat brain","volume":"23","author":"Chen","year":"2003","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-011-0087-4_bib73","first-page":"8899","article-title":"Adenosine 5'-triphosphate-sensitive potassium channel-mediated blood\u2013brain tumor barrier permeability increase in a rat brain tumor model","volume":"63","author":"Ningaraj","year":"2003","journal-title":"Cancer Res"},{"key":"10.1007\/s13311-011-0087-4_bib74","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainres.2007.01.133","article-title":"Bradykinin-induced blood\u2013brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel","volume":"1144","author":"Zhang","year":"2007","journal-title":"Brain Res"},{"key":"10.1007\/s13311-011-0087-4_bib75","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/STROKEAHA.109.572644","article-title":"Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke","volume":"41","author":"Simard","year":"2010","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0087-4_bib76","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1161\/01.STR.22.12.1519","article-title":"Atrial natriuretic factor and salt wasting after aneurysmal subarachnoid hemorrhage","volume":"22","author":"Wijdicks","year":"1991","journal-title":"Stroke"},{"key":"10.1007\/s13311-011-0087-4_bib77","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2265.2006.02432.x","article-title":"The incidence and pathophysiology of hyponatraemia after subarachnoid haemorrhage","volume":"64","author":"Sherlock","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1007\/s13311-011-0087-4_bib78","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.CCM.0000201903.46435.35","article-title":"Impact of medical complications on outcome after subarachnoid hemorrhage","volume":"34","author":"Wartenberg","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1007\/s13311-011-0087-4_bib79","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ana.410270118","article-title":"Hyponatremia is associated with cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage","volume":"27","author":"Hasan","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib80","first-page":"149","article-title":"Therapeutic recommendations for management of severe hyponatremia: current concepts on pathogenesis and prevention of neurologic complications","volume":"46","author":"Soupart","year":"1996","journal-title":"Clin Nephrol"},{"key":"10.1007\/s13311-011-0087-4_bib81","doi-asserted-by":"crossref","unstructured":"Upadhyay UM, Gormley WB. Etiology and management of hyponatremia in neurosurgical patients. J Intensive Care Med 2011;.","DOI":"10.1177\/0885066610395489"},{"key":"10.1007\/s13311-011-0087-4_bib82","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.nrl.0000215741.01699.77","article-title":"Hyponatremia in neurologic patients: consequences and approaches to treatment","volume":"12","author":"Diringer","year":"2006","journal-title":"Neurologist"},{"key":"10.1007\/s13311-011-0087-4_bib83","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1227\/01.NEU.0000358954.62182.B3","article-title":"Hyponatremia in neurosurgical patients: clinical guidelines development","volume":"65","author":"Rahman","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-011-0087-4_bib84","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1227\/00006123-199011000-00010","article-title":"Sustained increased cerebral blood flow with prophylactic hypertensive hypervolemic hemodilution (\"triple-H\" therapy) after subarachnoid hemorrhage","volume":"27","author":"Origitano","year":"1990","journal-title":"Neurosurgery"},{"key":"10.1007\/s13311-011-0087-4_bib85","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ana.410170206","article-title":"Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysms: is fluid restriction harmful?","volume":"17","author":"Wijdicks","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-011-0087-4_bib86","first-page":"637","article-title":"Fludrocortisone in the treatment of subarachnoid hemorrhage-induced hyponatremia","volume":"31","author":"Woo","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1007\/s13311-011-0087-4_bib87","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0303-8467(88)90023-6","article-title":"The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage","volume":"90","author":"Wijdicks","year":"1988","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1007\/s13311-011-0087-4_bib88","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1345\/aph.1H502","article-title":"Hyponatremia: current treatment strategies and the role of vasopressin antagonists","volume":"41","author":"Cawley","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1007\/s13311-011-0087-4_bib89","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1056\/NEJMe068236","article-title":"Vasopressin antagonists \u2014 progress and promise","volume":"355","author":"Hays","year":"2006","journal-title":"N Engl J Med"},{"issue":"7 suppl 1","key":"10.1007\/s13311-011-0087-4_bib90","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.amjmed.2006.05.014","article-title":"Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia","volume":"119","author":"Palm","year":"2006","journal-title":"Am J Med"},{"key":"10.1007\/s13311-011-0087-4_bib91","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","article-title":"Non-peptide arginine-vasopressin antagonists: the vaptans","volume":"371","author":"Decaux","year":"2008","journal-title":"Lancet"},{"key":"10.1007\/s13311-011-0087-4_bib92","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1159\/000106456","article-title":"Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia","volume":"27","author":"Zeltser","year":"2007","journal-title":"Am J Nephrol"},{"key":"10.1007\/s13311-011-0087-4_bib93","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000094539","article-title":"Vasopressin antagonists: role in the management of hyponatremia","volume":"26","author":"Yeates","year":"2006","journal-title":"Am J Nephrol"},{"key":"10.1007\/s13311-011-0087-4_bib94","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1210\/jc.2005-2287","article-title":"Efficacy and safety of oral conivaptan: a V1A\/V2 vasopressin receptor antagonist, assessed in a randomized, placebo-controlled trial in patients with euvolemic or hypervolemic hyponatremia","volume":"91","author":"Ghali","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1007\/s13311-011-0087-4_bib95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12028-008-9179-3","article-title":"Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit","volume":"11","author":"Murphy","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-011-0087-4_bib96","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-008-9152-1","article-title":"Conivaptan for hyponatremia in the neurocritical care unit","volume":"11","author":"Wright","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-011-0087-4_bib97","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF01420062","article-title":"Cerebral oedema after subarachnoid haemorrhage. Pathogenetic significance of vasopressin","volume":"133","author":"L\u00e1szl\u00f3","year":"1995","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1007\/s13311-011-0087-4_bib98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12028-010-9366-x","article-title":"A bolus of conivaptan lowers intracranial pressure in a patient with hyponatremia after traumatic brain injury","volume":"14","author":"Dhar","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1007\/s13311-011-0087-4_bib99","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12028-011-9525-8","article-title":"Open-label randomized trial of the safety and efficacy of a single dose conivaptan to raise serum sodium in patients with traumatic brain injury","volume":"14","author":"Galton","year":"2011","journal-title":"Neurocrit Care"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-011-0087-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-011-0087-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923017683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923017683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-011-0087-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:10:05Z","timestamp":1761808205000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923017683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1878747923017683"],"URL":"https:\/\/doi.org\/10.1007\/s13311-011-0087-4","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel Treatment Targets for Cerebral Edema","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-011-0087-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}